Effect of strict blood glucose control on residual B-cell function in insulin-dependent diabetics
- PMID: 7026327
- DOI: 10.1007/BF00252760
Effect of strict blood glucose control on residual B-cell function in insulin-dependent diabetics
Abstract
In 14 insulin dependent diabetics past their initial remission period B-cell function was evaluated using a test meal before and after 1 week of strict blood glucose control, and again 3 weeks later when the patients were outpatients on conventional therapy. Eight patients with fasting C-peptide above 0.07 nmol/l improved their B-cell function significantly (p Less Than 0.05) during the period of strict blood glucose control. However, the improvement was of short duration and was absent 3 weeks later in most patients. Six patients with fasting C-peptide below or equal to 0.07 nmol/l had no significant improvement in B-cell function during the period of strict control. The study shows that B-cell function and degree of blood glucose control are related in patients with fasting C-peptide above 0.07 nmol/l, and that B-cell function can change within days.
Similar articles
-
Diurnal profiles of intermediary metabolites in insulin-dependent diabetes and their relationship to different degrees of residual B-cell function.Acta Diabetol Lat. 1981 Apr-Jun;18(2):115-21. doi: 10.1007/BF02098996. Acta Diabetol Lat. 1981. PMID: 7018146
-
Residual pancreatic function in insulin dependent diabetics.Aust N Z J Med. 1982 Feb;12(1):43-7. doi: 10.1111/j.1445-5994.1982.tb02424.x. Aust N Z J Med. 1982. PMID: 7044357
-
Effect of two periods with intensified insulin treatment on B-cell function during the first 18 months of type 1 (insulin-dependent) diabetes mellitus.Diabete Metab. 1986 Oct;12(5):256-60. Diabete Metab. 1986. PMID: 3542618 Clinical Trial.
-
The transient effect of strict glycaemic control on B cell function in newly diagnosed type 1 (insulin-dependent) diabetic patients.Diabetologia. 1982 Jan;22(1):16-20. doi: 10.1007/BF00253863. Diabetologia. 1982. PMID: 7037505 Clinical Trial.
-
C-peptide measurement and its clinical usefulness: a review.Ann Clin Biochem. 1981 Jul;18(Pt 4):200-6. doi: 10.1177/000456328101800402. Ann Clin Biochem. 1981. PMID: 7025733 Review. No abstract available.
Cited by
-
Residual C-peptide in patients with Type 1 diabetes and multiethnic backgrounds.Clinics (Sao Paulo). 2013 Jan;68(1):123-6. doi: 10.6061/clinics/2013(01)rc02. Clinics (Sao Paulo). 2013. PMID: 23420171 Free PMC article.
-
Prevalence of residual B cell function and its metabolic consequences in Type 1 (insulin-dependent) diabetes.Diabetologia. 1983 Mar;24(3):141-7. doi: 10.1007/BF00250151. Diabetologia. 1983. PMID: 6341142 No abstract available.
-
Spontaneous complete remission of type 1 diabetes mellitus in an adult - review and case report.J Community Hosp Intern Med Perspect. 2015 Oct 19;5(5):28709. doi: 10.3402/jchimp.v5.28709. eCollection 2015. J Community Hosp Intern Med Perspect. 2015. PMID: 26486109 Free PMC article.
-
Lack of effect of intermittently administered sodium fusidate in patients with newly diagnosed type 1 diabetes mellitus: the FUSIDM trial.Diabetologia. 2005 Aug;48(8):1464-8. doi: 10.1007/s00125-005-1823-2. Epub 2005 Jul 2. Diabetologia. 2005. PMID: 15995847 Clinical Trial.
-
Glycaemic control and suppressor cell activity in patients with insulin-dependent diabetes mellitus.Clin Exp Immunol. 1982 Apr;48(1):189-95. Clin Exp Immunol. 1982. PMID: 7044628 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous